4//SEC Filing
H&S INVESTMENTS I LP 4
Accession 0001209191-21-009411
CIK 0001829802other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:44 PM ET
Size
13.4 KB
Accession
0001209191-21-009411
Insider Transaction Report
Form 4
H&S INVESTMENTS I LP
10% Owner
Transactions
- Conversion
Common Stock
2021-02-08+4,361,835→ 4,425,998 total - Conversion
Series AA Convertible Preferred Stock
2021-02-08−209,368,245→ 0 total→ Common Stock (4,361,835 underlying)
Footnotes (2)
- [F1]Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.
- [F2]The shares are held by H&S Investments I, L.P ("H&S Investments"), H&S Ventures, LLC ("H&S Ventures"), its general partner, and Michael Shulman, manager of H&S Ventures may be deemed to have voting and dispositive power with respect to the shares held. Henry Samueli and Susan Samueli are the non-managing members of H&S Ventures and each have the right to replace the managing member of H&S Ventures at any time. Henry Samueli and Susan Samueli may be deemed to beneficially own any shares directly owned by H&S Investments.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001219243
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 6:44 PM ET
- Size
- 13.4 KB